Literature DB >> 31485766

METase/lncRNA HULC/FoxM1 reduced cisplatin resistance in gastric cancer by suppressing autophagy.

Lin Xin1, Qi Zhou2, Yi-Wu Yuan2, Li-Qiang Zhou2, Li Liu2, Shi-Hao Li2, Chuan Liu2.   

Abstract

BACKGROUND: Autophagy plays an important role in regulating cisplatin (CDDP) resistance in gastric cancer cells. However, the underlying mechanism of methioninase (METase) in the regulation of autophagy and CDDP resistance of gastric cancer cells is still not clear.
MATERIALS AND METHODS: Western blot was used to detect the levels of autophagy-related proteins, multidrug-resistant 1 (MDR-1), and FoxM1 protein. LncRNA HULC was detected by qRT-PCR. Cell viability was detected using CCK-8 assay. The interaction between lncRNA HULC and FoxM1 was confirmed by RNA pull-down and RIP assay.
RESULTS: Lentiviral vector carrying METase (LV-METase) suppressed autophagy and CDDP resistance of drug-resistant gastric cancer cells. LncRNA HULC was significantly downregulated in drug-resistant gastric cancer cells transfected with LV-METase. Besides, we found that lncRNA HULC interacted with FoxM1. In addition, METase suppressed autophagy to reduce CDDP resistance of drug-resistant gastric cancer cells through regulating HULC/FoxM1, and interfering HULC suppressed autophagy to reduce CDDP resistance of drug-resistant gastric cancer cells through regulating FoxM1. Finally, interfering HULC inhibited tumor growth in vivo.
CONCLUSION: METase suppressed autophagy to reduce CDDP resistance of drug-resistant gastric cancer cells through regulating HULC/FoxM1 pathway.

Entities:  

Keywords:  Cisplatin resistance; FoxM1; Gastric cancer; Methioninase; lncRNA HULC

Mesh:

Substances:

Year:  2019        PMID: 31485766     DOI: 10.1007/s00432-019-03015-w

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  23 in total

1.  Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer.

Authors:  Kei Kawaguchi; Kentaro Miyake; Qinghong Han; Shukuan Li; Yuying Tan; Kentaro Igarashi; Thinzar M Lwin; Takashi Higuchi; Tasuku Kiyuna; Masuyo Miyake; Hiromichi Oshiro; Michael Bouvet; Michiaki Unno; Robert M Hoffman
Journal:  Cell Cycle       Date:  2018-05-21       Impact factor: 4.534

2.  Recombinant methioninase in combination with doxorubicin (DOX) overcomes first-line DOX resistance in a patient-derived orthotopic xenograft nude-mouse model of undifferentiated spindle-cell sarcoma.

Authors:  Kentaro Igarashi; Kei Kawaguchi; Shukuan Li; Qinghong Han; Yuying Tan; Takashi Murakami; Tasuku Kiyuna; Kentaro Miyake; Masuyo Miyake; Arun S Singh; Mark A Eckardt; Scott D Nelson; Tara A Russell; Sarah M Dry; Yunfeng Li; Norio Yamamoto; Katsuhiro Hayashi; Hiroaki Kimura; Shinji Miwa; Hiroyuki Tsuchiya; Shree Ram Singh; Fritz C Eilber; Robert M Hoffman
Journal:  Cancer Lett       Date:  2018-01-03       Impact factor: 8.679

3.  Knockdown of the FoxM1 enhances the sensitivity of gastric cancer cells to cisplatin by targeting Mcl-1.

Authors:  Xiaomei Li; Jun Liang; Ying-Xun Liu; Yuming Wang; Xiao-Hui Yang; Gui-Lling Zhang; Juan Du; Xia-Hong Wu
Journal:  Pharmazie       Date:  2016-06       Impact factor: 1.267

4.  Methionine depletion with recombinant methioninase: in vitro and in vivo efficacy against neuroblastoma and its synergism with chemotherapeutic drugs.

Authors:  Jian Hu; Nai-Kong V Cheung
Journal:  Int J Cancer       Date:  2009-04-01       Impact factor: 7.396

Review 5.  Targeting autophagy to overcome drug resistance in cancer therapy.

Authors:  Ankit Kumar; Umesh Kumar Singh; Anurag Chaudhary
Journal:  Future Med Chem       Date:  2015-08-26       Impact factor: 3.808

6.  miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2.

Authors:  Y An; Z Zhang; Y Shang; X Jiang; J Dong; P Yu; Y Nie; Q Zhao
Journal:  Cell Death Dis       Date:  2015-05-21       Impact factor: 8.469

7.  Recombinant methioninase (rMETase) is an effective therapeutic for BRAF-V600E-negative as well as -positive melanoma in patient-derived orthotopic xenograft (PDOX) mouse models.

Authors:  Kei Kawaguchi; Kentaro Igarashi; Shukuan Li; Qinghong Han; Yuying Tan; Kentaro Miyake; Tasuku Kiyuna; Masuyo Miyake; Takashi Murakami; Bartosz Chmielowski; Scott D Nelson; Tara A Russell; Sarah M Dry; Yunfeng Li; Michiaki Unno; Fritz C Eilber; Robert M Hoffman
Journal:  Oncotarget       Date:  2017-12-12

8.  The lncRNA HULC functions as an oncogene by targeting ATG7 and ITGB1 in epithelial ovarian carcinoma.

Authors:  Shuo Chen; Dan-Dan Wu; Xiu-Bo Sang; Li-Li Wang; Zhi-Hong Zong; Kai-Xuan Sun; Bo-Liang Liu; Yang Zhao
Journal:  Cell Death Dis       Date:  2017-10-12       Impact factor: 8.469

9.  RNF168 cooperates with RNF8 to mediate FOXM1 ubiquitination and degradation in breast cancer epirubicin treatment.

Authors:  M Kongsema; S Zona; U Karunarathna; E Cabrera; E P S Man; S Yao; A Shibakawa; U-S Khoo; R H Medema; R Freire; E W-F Lam
Journal:  Oncogenesis       Date:  2016-08-15       Impact factor: 7.485

10.  Intra-tumor L-methionine level highly correlates with tumor size in both pancreatic cancer and melanoma patient-derived orthotopic xenograft (PDOX) nude-mouse models.

Authors:  Kei Kawaguchi; Qinghong Han; Shukuan Li; Yuying Tan; Kentaro Igarashi; Kentaro Miyake; Tasuku Kiyuna; Masuyo Miyake; Bartosz Chemielwski; Scott D Nelson; Tara A Russell; Sarah M Dry; Yunfeng Li; Arun S Singh; Mark A Eckardt; Michiaki Unno; Fritz C Eilber; Robert M Hoffman
Journal:  Oncotarget       Date:  2018-01-17
View more
  29 in total

Review 1.  Introduction of long non-coding RNAs to regulate autophagy-associated therapy resistance in cancer.

Authors:  Yanyan Wang; Zhaoping Liu; Zhenru Xu; Wenjun Shao; Dingyu Hu; Huiying Zhong; Ji Zhang
Journal:  Mol Biol Rep       Date:  2022-07-09       Impact factor: 2.316

2.  Long non-coding RNA (FALEC) promotes malignant behaviors of gastric cancer cells by regulating miR-203b/PIM3 axis.

Authors:  Wenjing Dong; Mancheng Gong; Jianjun Xiao; Huifen Li; Muyou Tian; Senming Wang
Journal:  Ann Transl Med       Date:  2022-05

3.  Long non-coding RNA HOXA11-AS knockout inhibits proliferation and overcomes drug resistance in ovarian cancer.

Authors:  Yuwei Chen; Zhaolei Cui; Qiaoling Wu; Huihui Wang; Hongmei Xia; Yang Sun
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

4.  lncRNA ZNF649-AS1 Induces Trastuzumab Resistance by Promoting ATG5 Expression and Autophagy.

Authors:  Mingli Han; Xueke Qian; Hui Cao; Fang Wang; Xiangke Li; Na Han; Xue Yang; Yunqing Yang; Dongwei Dou; Jianguo Hu; Wei Wang; Jing Han; Fan Zhang; Huaying Dong
Journal:  Mol Ther       Date:  2020-07-21       Impact factor: 11.454

Review 5.  Autophagy and gastrointestinal cancers: the behind the scenes role of long non-coding RNAs in initiation, progression, and treatment resistance.

Authors:  Rana Shafabakhsh; Farzaneh Arianfar; Massoud Vosough; Hamid Reza Mirzaei; Maryam Mahjoubin-Tehran; Hashem Khanbabaei; Hamed Kowsari; Layla Shojaie; Maryam Ebadi Fard Azar; Michael R Hamblin; Hamed Mirzaei
Journal:  Cancer Gene Ther       Date:  2021-01-11       Impact factor: 5.987

Review 6.  Exploring the role of non-coding RNAs in autophagy.

Authors:  Soudeh Ghafouri-Fard; Hamed Shoorei; Mahdi Mohaqiq; Jamal Majidpoor; Mohammad Amin Moosavi; Mohammad Taheri
Journal:  Autophagy       Date:  2021-02-18       Impact factor: 13.391

7.  Quantitative Proteomics Analysis Indicates That Upregulation of lncRNA HULC Promotes Pathogenesis of Glioblastoma Cells.

Authors:  Yuchen Hu; Shan Ye; Qian Li; Tiantian Yin; Jing Wu; Jie He
Journal:  Onco Targets Ther       Date:  2020-06-22       Impact factor: 4.147

8.  LncRNA UCA1 promotes cisplatin resistance in gastric cancer via recruiting EZH2 and activating PI3K/AKT pathway.

Authors:  Qingqiang Dai; Tianqi Zhang; Jiaomeng Pan; Chen Li
Journal:  J Cancer       Date:  2020-04-06       Impact factor: 4.207

9.  Long noncoding RNA HULC contributes to paclitaxel resistance in ovarian cancer via miR-137/ITGB8 axis.

Authors:  Bo Huang; Min Wei; Li Hong
Journal:  Open Life Sci       Date:  2021-07-01       Impact factor: 0.938

Review 10.  Long non-coding RNAs in gastric cancer: New emerging biological functions and therapeutic implications.

Authors:  Huidan Tan; Shouyue Zhang; Jin Zhang; Lingjuan Zhu; Yanmei Chen; Hongmei Yang; Yi Chen; Yang An; Bo Liu
Journal:  Theranostics       Date:  2020-07-11       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.